Compare Fox Corp Class A (FOXA) vs Merck & Co., Inc. (MRK) Price & Performance

Fox Corp Class ATrade

Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

Fox Corp Class A vs Merck & Co., Inc. — how do they compare? Fox Corp Class A trades at $61.87 (market cap $24.58B), while Merck & Co., Inc. trades at $129.69 (market cap $321.77B). The key difference: Merck & Co., Inc. is far larger — about 13.1× Fox Corp Class A's market cap, and Merck & Co., Inc. pays the higher dividend (2.61%). Which is the better fit depends on your goals.

	FOXA	MRK
Market Cap	$24.58B	$321.77B
Sector	Media	Health
52-Week High	$76.11	$131.84
52-Week Low	$48.79	$77.60
Enterprise Value	$27.94B	$368.53B
Dividend Yield	0.93%	2.61%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fox Corp Class A

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $130.9, up 1.81% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $140.36. Recent earnings beats and a 72.97% gross margin highlight strong profitability, while the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline. The stock faces headwinds from a high P/E ratio of 104.34 and fluctuating cash flows.

The outlook is positive with robust fundamentals and strategic M&A, but valuation concerns and competitive pressures in pharma pose risks. Upside is likely if earnings growth continues, though investors should monitor debt levels and integration of acquisitions.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FOXA

Gracenote partners with Tubi Media to enhance content discovery and targeted ads on streaming platforms.PRNewsWire · 4 hours agoBullish View details →

MRK

Revolution Medicines hits $44B market cap with breakthrough RAS cancer drugs, attracting big pharma interest.24/7 Wall Street · 4 hours agoBullish Bio-Techne reports flat FY2026 revenue, EPS rise, and confirms $11.3B acquisition by Merck KGaA.PRNewsWire · 6 hours agoBullish Trump orders splitting MMR vaccine into three shots despite no scientific support and expert criticism.CNBC · 1 day agoBearish View details →

About Fox Corp Class A

Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.